SRNE Stock Recent News
SRNE LATEST HEADLINES
The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug application (IND) for Abivertinib (Fujovee) for Phase 2 MAVERICK study in metastatic castrate-resistant prostate cancer (mCRPC). The MAVERICK study will be conducted in a partnership.
Benzinga 2022 May 17
The company delivers some encouraging news about a COVID drug.
The Motley Fool 2022 May 02
Check these three penny stocks out as the stock market falls The post 3 Penny Stocks to Watch During the Stock Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks 2022 May 02